Kumar, P., Liu, C., Suliburk, J., Hsu, J
Tirzepatide (Mounjaro) works similarly but is classified as a dual GIP/GLP-1 receptor agonist
Tirzepatides efficacy in MASH treatment is just one facet of ongoing research into its broader therapeutic potential
SIDE EFFECTS Common: Peripheral edema (ankle swelling very common, dose-dependent), headache, flushing, palpitations, dizziness, fatigue
How do you monitor for side effects and adjust protocols? Should describe regular check-ins, symptom monitoring, and lab-based adjustments
Naltrexone dose will increase monthly until maintenance dosing around month 3 and you will only need to come to the practice for weight checks monthly and follow up labs quarterly